HeartBeam Stock (NASDAQ: BEAT) stock price, news, charts, stock research, profile.
Open | $1.990 |
Close | $2.000 |
Volume / Avg. | 23.121K / 124.527K |
Day Range | 1.970 - 2.050 |
52 Wk Range | 1.060 - 3.740 |
Market Cap | $52.395M |
P/E Ratio | - |
Dividend Yield | - |
Exchange | NASDAQ |
RSI | 50 |
Short Interest | 0.74% |
Days to Cover | 1.31 |
Name |
---|
Revenue Change |
Gross Change |
EBITDA Change |
EBIT Change |
Earnings Change |
You can purchase shares of HeartBeam (NASDAQ: BEAT) through any online brokerage.
Other companies in HeartBeam’s space includes: Pro-Dex (NASDAQ:PDEX), LENSAR (NASDAQ:LNSR), Asensus Surgical (AMEX:ASXC), Autonomix Medical (NASDAQ:AMIX) and Modular Medical (NASDAQ:MODD).
The latest price target for HeartBeam (NASDAQ: BEAT) was reported by Benchmark on Monday, March 25, 2024. The analyst firm set a price target for 8.00 expecting BEAT to rise to within 12 months (a possible 300.00% upside). 5 analyst firms have reported ratings in the last year.
The stock price for HeartBeam (NASDAQ: BEAT) is $2 last updated April 26, 2024 at 3:59 PM EDT.
There are no upcoming dividends for HeartBeam.
HeartBeam’s Q1 earnings are confirmed for Thursday, May 9, 2024.
There is no upcoming split for HeartBeam.
HeartBeam is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NASDAQ.